KRYS
Price
$265.28
Change
-$14.29 (-5.11%)
Updated
Feb 4, 02:56 PM (EDT)
Capitalization
8.11B
26 days until earnings call
Intraday BUY SELL Signals
LENZ
Price
$14.71
Change
-$0.82 (-5.28%)
Updated
Feb 4, 02:57 PM (EDT)
Capitalization
485.46M
Intraday BUY SELL Signals
Interact to see
Advertisement

KRYS vs LENZ

Header iconKRYS vs LENZ Comparison
Open Charts KRYS vs LENZBanner chart's image
Krystal Biotech
Price$265.28
Change-$14.29 (-5.11%)
Volume$875
Capitalization8.11B
LENZ Therapeutics
Price$14.71
Change-$0.82 (-5.28%)
Volume$100
Capitalization485.46M
KRYS vs LENZ Comparison Chart in %
View a ticker or compare two or three
VS
KRYS vs. LENZ commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a Hold and LENZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (KRYS: $279.57 vs. LENZ: $15.53)
Brand notoriety: KRYS and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 50% vs. LENZ: 50%
Market capitalization -- KRYS: $8.11B vs. LENZ: $485.46M
KRYS [@Biotechnology] is valued at $8.11B. LENZ’s [@Biotechnology] market capitalization is $485.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 1 FA rating(s) are green whileLENZ’s FA Score has 1 green FA rating(s).

  • KRYS’s FA Score: 1 green, 4 red.
  • LENZ’s FA Score: 1 green, 4 red.
According to our system of comparison, KRYS is a better buy in the long-term than LENZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 4 TA indicator(s) are bullish while LENZ’s TA Score has 2 bullish TA indicator(s).

  • KRYS’s TA Score: 4 bullish, 4 bearish.
  • LENZ’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than LENZ.

Price Growth

KRYS (@Biotechnology) experienced а +0.80% price change this week, while LENZ (@Biotechnology) price change was -19.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

KRYS is expected to report earnings on Mar 02, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($8.11B) has a higher market cap than LENZ($485M). LENZ has higher P/E ratio than KRYS: LENZ (48.03) vs KRYS (41.91). KRYS YTD gains are higher at: 13.397 vs. LENZ (-2.938). KRYS has higher annual earnings (EBITDA): 165M vs. LENZ (-67.7M). KRYS has more cash in the bank: 731M vs. LENZ (202M). LENZ has less debt than KRYS: LENZ (954K) vs KRYS (9.51M). KRYS has higher revenues than LENZ: KRYS (373M) vs LENZ (17.5M).
KRYSLENZKRYS / LENZ
Capitalization8.11B485M1,671%
EBITDA165M-67.7M-244%
Gain YTD13.397-2.938-456%
P/E Ratio41.9148.0387%
Revenue373M17.5M2,131%
Total Cash731M202M362%
Total Debt9.51M954K997%
FUNDAMENTALS RATINGS
KRYS: Fundamental Ratings
KRYS
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
19
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KRYSLENZ
RSI
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 14 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
72%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
KRYS
Daily Signal:
Gain/Loss:
LENZ
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DBIWX11.690.05
+0.43%
DWS Global Macro R6
FDTZX25.58N/A
N/A
Fidelity Advisor Capital Development M
SSCYX6.03-0.01
-0.17%
Saratoga Small Capitalization A
PXNIX12.80-0.05
-0.39%
Impax International Sust Econ Instl
UMLGX6.70-0.17
-2.47%
Columbia Select Large Cap Growth Inst

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with VRDN. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-0.96%
VRDN - KRYS
52%
Loosely correlated
-3.92%
XNCR - KRYS
51%
Loosely correlated
-0.99%
NUVL - KRYS
50%
Loosely correlated
+2.12%
CGON - KRYS
49%
Loosely correlated
-3.28%
CRNX - KRYS
46%
Loosely correlated
+1.24%
More

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with BEAM. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
-4.72%
BEAM - LENZ
41%
Loosely correlated
-0.11%
OCUL - LENZ
41%
Loosely correlated
-6.99%
DNLI - LENZ
40%
Loosely correlated
-4.22%
KRYS - LENZ
40%
Loosely correlated
-0.96%
NUVB - LENZ
40%
Loosely correlated
+4.80%
More